According to Novo Nordisk latest financial reports the total liabilities of NVO is $30.98B, an increase of 31.79% to 2022. At the end of 2022 company had $23.50B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Novo Nordisk is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $30.98B | 31.79% |
2022 | $23.50B | 27.48% |
2021 | $18.44B | 51.67% |
2020 | $12.16B | 19.96% |
2019 | $10.13B | 631.78% |
2018 | $1.38B | - |